ketanserin has been researched along with Complex Regional Pain Syndrome in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reuben, SS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Complex Regional Pain Syndrome Using Liposomal Encapsulated Vitamin C in Programmed Knee Surgery; A Prospective Randomized Trial[NCT04204200] | 66 participants (Actual) | Interventional | 2014-01-06 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Radiographs of the knee in Schuss with an external decoaptation which must be close to 0 cm and a pan gono gram standing from the front (NCT04204200)
Timeframe: After one-year follow-up
| Intervention | participants (Number) |
|---|---|
| Allocated to Conventional Vitamin C (n= 22) | 0 |
| Allocated to Liposomal Vitamin C (n= 22) | 0 |
| Allocated to Placebo (n= 22) | 0 |
Radiographs of the knee in monopodial support at 30° flexion (schuss) were taken. Measurement analysis of the translation of the tibia relative to the femur which must be close to 0 cm for the patient to be positive for the outcome. (NCT04204200)
Timeframe: After one-year follow-up
| Intervention | participants (Number) |
|---|---|
| Allocated to Conventional Vitamin C (n= 22) | 1 |
| Allocated to Liposomal Vitamin C (n= 22) | 0 |
| Allocated to Placebo (n= 22) | 0 |
X-rays of the knee and Schuss profile with an internal and external decoaptation which must be close to 0 cm with pan gonogram standing from the front (x-rays of the long axes of the pelvis of the ankles with measurement of the HKA axes on the prosthesis side and on the non-side operated which must be close to 180°) to have eccentric arthritis. (NCT04204200)
Timeframe: After one-year follow-up
| Intervention | participants (Number) |
|---|---|
| Allocated to Conventional Vitamin C (n= 22) | 1 |
| Allocated to Liposomal Vitamin C (n= 22) | 0 |
| Allocated to Placebo (n= 22) | 2 |
We take an x-ray of the knee then we calculate of the Index of Caton and Deschamps AT / AP which must be close to 1 cm (from the upper edge to the lower edge of the patella which must be equal to the distance between the tip of the patella and anterior tibial tuberosity) to be interpreted as a transposed tuberosity. (NCT04204200)
Timeframe: After one-year of follow-up
| Intervention | participants (Number) |
|---|---|
| Allocated to Conventional Vitamin C (n= 22) | 1 |
| Allocated to Liposomal Vitamin C (n= 22) | 0 |
| Allocated to Placebo (n= 22) | 2 |
1 review available for ketanserin and Complex Regional Pain Syndrome
| Article | Year |
|---|---|
Preventing the development of complex regional pain syndrome after surgery.
Topics: Analgesics; Anesthesia, Conduction; Anesthesia, Epidural; Calcitonin; Complex Regional Pain Syndrome | 2004 |